DR. WILLIAM ALLEN BANKS, M.D.
Osteopathic Medicine at Grand Blvd, Saint Louis, MO
License number
Missouri 114533
Category
Osteopathic Medicine
Type
Geriatric Medicine
Address
Address
915 N Grand Blvd, Saint Louis, MO 63106
Phone
(314) 289-7084
(314) 289-6374 (Fax)
(314) 289-6374 (Fax)
Professional information
William Allen Banks, Saint Louis MO
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Geriatric Medicine
Work:
Vamc 111c-Jc
915 N Grand Blvd, Saint Louis, MO 63106
915 N Grand Blvd, Saint Louis, MO 63106
Education:
University of Missouri at Columbia (1979)
Dr. William A Banks - MD (Doctor of Medicine)
Hospitals:
1660 S Columbian Way, Seattle 98108
915 N Grand Blvd, Saint Louis 63106
VA PSHCS DEPARTMENT OF NEUROLOGY
1660 S Columbian Way STE 358280, Seattle 98108
1660 S Columbian Way, Seattle 98108
915 N Grand Blvd, Saint Louis 63106
VA PSHCS DEPARTMENT OF NEUROLOGY
1660 S Columbian Way STE 358280, Seattle 98108
915 N Grand Blvd, Saint Louis 63106
VA PSHCS DEPARTMENT OF NEUROLOGY
1660 S Columbian Way STE 358280, Seattle 98108
1660 S Columbian Way, Seattle 98108
915 N Grand Blvd, Saint Louis 63106
VA PSHCS DEPARTMENT OF NEUROLOGY
1660 S Columbian Way STE 358280, Seattle 98108
Education:
Medical Schools
University of Missouri / Columbia Campus
Graduated: 1979
University of Missouri / Columbia Campus
Graduated: 1979
Antisense Modulation Of Amyloid Beta Protein Expression
US Patent:
2011016, Jul 7, 2011
Filed:
Feb 19, 2009
Appl. No.:
12/918402
Inventors:
Thomas Darling - Saint Louis MO, US
Vijaya B. Kumar - Saint Louis MO, US
William A. Banks - Saint Louis MO, US
Susan Farr - Saint Louis MO, US
John E. Morley - Saint Louis MO, US
Vijaya B. Kumar - Saint Louis MO, US
William A. Banks - Saint Louis MO, US
Susan Farr - Saint Louis MO, US
John E. Morley - Saint Louis MO, US
Assignee:
EDUNN BIOTECHNOLOGY, INC. - St. Louis MO
International Classification:
A61K 31/7088, C07H 21/04, C12N 5/071, A61P 25/28, A61P 25/16, A61P 25/00, A61P 7/04
US Classification:
514 44 A, 536 231, 536 245, 514 44 R, 435375
Abstract:
Antisense nucleic acids, compositions and methods are provided for modulating the expression of an amyloid beta protein (AβP) portion of the amyloid precursor protein (APP) coding sequence. The compositions comprise antisense nucleic acids targeted to nucleic acids encoding amyloid precursor protein. Methods of using these nucleic acids for modulation of amyloid precursor protein expression and for treatment of diseases and conditions associated with expression of the amyloid beta protein portion of the amyloid precursor protein are provided.
Modulation Of Blood Brain Barrier Protein Expression
US Patent:
8466118, Jun 18, 2013
Filed:
Apr 23, 2008
Appl. No.:
12/597458
Inventors:
William A. Banks - Saint Louis MO, US
Vijaya B. Kumar - Saint Louis MO, US
Thomas Darling - Saint Louis MO, US
Robert Clayton - Foristell MO, US
Vijaya B. Kumar - Saint Louis MO, US
Thomas Darling - Saint Louis MO, US
Robert Clayton - Foristell MO, US
Assignee:
Saint Louis University - St. Louis MO
International Classification:
A01N 43/04, C12Q 1/68, C12N 15/63, C07H 21/02, C07H 21/04
US Classification:
514 44, 435 6, 435 911, 435 9131, 435455, 514 1, 514 2, 536 231, 536 243, 536 245
Abstract:
There are disclosed agents that inhibit Blood Brain Barrier Proteins (BBBP). Such agents are useful in controlling agents entering and exiting the CNS. This allows for drugs to be more effective and/or allowing side effects of the drugs to be lowered.